+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Optic Neuritis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768106
  • Report
  • April 2019
  • Region: Global
  • 134 pages
  • VPA Research

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Alpharma Ltd
  • Atrium Innovations Inc
  • Biogen Inc
  • Bionure Farma SL
  • E. Merck KG
The global clinical trial report- “2019 Optic Neuritis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Optic Neuritis. It presents in-depth analysis of Optic Neuritis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Optic Neuritis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Optic Neuritis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Optic Neuritis

The research work is prepared through extensive and continuous research on Optic Neuritis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Optic Neuritis patients are identified
  • The report includes panorama of Optic Neuritis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Optic Neuritis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Alpharma Ltd
  • Atrium Innovations Inc
  • Biogen Inc
  • Bionure Farma SL
  • E. Merck KG
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Optic Neuritis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Optic Neuritis Clinical Trials by Region
2.2.2 Average Enrollment of Optic Neuritis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Optic Neuritis Treatment, 2019

3. Region wise Optic Neuritis Clinical Trials
3.1 Asia Pacific Optic Neuritis Clinical Trials by Country
3.2 Europe Optic Neuritis Clinical Trials by Country
3.3 North America Optic Neuritis Clinical Trials by Country
3.4 Middle East and Africa Optic Neuritis Clinical Trials by Country
3.5 South and Central America Optic Neuritis Clinical Trials by Country

4. Optic Neuritis Clinical Trial Trends
4.1 Start Year wise Optic Neuritis Clinical Trials
4.2 Phase wise Optic Neuritis Clinical Trials
4.3 Trial Status wise Optic Neuritis Clinical Trials
4.4 Trial Type wise Optic Neuritis Clinical Trials

5. Optic Neuritis Average Enrollment Trends
5.1 Average Enrollment in Optic Neuritis Trials by Year
5.2 Average Enrollment in Optic Neuritis Trials by Phase
5.3 Average Enrollment in Optic Neuritis Trials by Status
5.4 Average Enrollment in Optic Neuritis Trials by Type of Trial

6. Companies Participating in Optic Neuritis Clinical Trials
6.1 Optic Neuritis Trials by Sponsor Type
6.2 Optic Neuritis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Optic Neuritis Trials- Phase 1
7.2 Optic Neuritis Trials- Phase 2
7.3 Optic Neuritis Trials- Phase 3
7.4 Optic Neuritis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Optic Neuritis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Optic Neuritis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Optic Neuritis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Optic Neuritis Clinical Trials and Enrolment
Figure 7: North America - Country wise Optic Neuritis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Optic Neuritis Clinical Trials and Enrolment
Figure 9: Optic Neuritis Clinical Trials by Phase
Figure 10: Optic Neuritis Clinical Trials by Trial Status
Figure 11: Optic Neuritis Clinical Trials by Type
Figure 12: Optic Neuritis Clinical Trials by Sponsor Type
Figure 13: Optic Neuritis Clinical Trials by Leading Sponsors
Figure 14: Optic Neuritis Average Enrollment by Phase
Figure 15: Optic Neuritis Average Enrollment by Trial Status
Figure 16: Optic Neuritis Average Enrollment by Type
Figure 17: Optic Neuritis- Average Enrolment by Type of Sponsors
Figure 18: Optic Neuritis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Optic Neuritis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Optic Neuritis Clinical Trials and Enrolment
Table 5: Europe - Country wise Optic Neuritis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Optic Neuritis Clinical Trials and Enrolment
Table 7: North America - Country wise Optic Neuritis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Optic Neuritis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Optic Neuritis Average Enrollment by Phase
Table 15: Optic Neuritis Average Enrollment by Trial Status
Table 16: Optic Neuritis Average Enrollment by Type
Table 17: Optic Neuritis- Average Enrolment by Type of Sponsors
Table 18: Optic Neuritis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
  • Acorda Therapeutics Inc
  • Alpharma Ltd
  • Atrium Innovations Inc
  • Biogen Inc
  • Bionure Farma SL
  • Consultants in Neurology LTD
  • E. Merck KG
  • MallInckrodt Plc
  • Meta-IQ ApS
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll